Credo Technology opens coverage at Watchlist. The shares traded at $249.64 on August 18, down 11.7% on the day and below the previous close of $282.82.

Q: Is this a weak business being passed over on principle?

A: The opposite. Fiscal 2026 revenue tripled to $1.335 billion at a 68% gross margin, non-GAAP net income rose more than fivefold to $661.5 million, and free cash flow reached $407 million. Return on invested capital is 73%, and the balance sheet holds $1.44 billion of cash against $25 million of debt. The report scores business quality, financial strength and growth potential at 9 out of 10 each.

Q: Then why Watchlist?

A: The arithmetic inside the guidance. Management guided fiscal 2027 to more than 80% revenue growth, then separately said the first half would grow at mid-single-digit sequential rates. The September quarter is guided to $470 million at the midpoint, up 7.6%. Holding both statements together puts roughly 60% of the year in the second half and requires the sequential rate to jump to about 34% in the January quarter.

Q: Can the company actually do that?

A: It has before. The January 2026 quarter grew 52% sequentially. But that is a precedent rather than a trend, and the last two reported quarters and the current guide all sit near 7.5%.

Q: Is that risk reflected in the price?

A: No. The published forward multiple implies a street estimate near $6.13 of non-GAAP earnings, which is the guided year almost exactly. Had the recent sequential pace simply continued, fiscal 2027 revenue would land near $2.10 billion and growth near 57%, a shortfall of roughly $300 million of revenue and $0.78 of earnings against an estimate carrying no discount. The shares closed on August 17 at $282.82, within a dollar of the $283.23 average analyst target.

Q: What else sits on the risk side?

A: Four customers each exceeded 10% of revenue in the June quarter. Beta is 3.23 and realised volatility runs above 100%. Officers have sold roughly $34 million of stock since late July. Results land on September 1, against a bar built from beats of 62%, 60%, 27% and 18%.

Q: What would change the call?

A: A September quarter guiding December above $520 million would turn the second-half story from an assertion into a trend and make this a Buy immediately. Failing that, $195 to $205, roughly 32 times the base-case estimate. Probability-weighted fair value is $237.

Scorecard and scenario detail are set out in the complete Credo Technology (CRDO) report on our Reports page.